White House asks for additional $4 billion for FEMA after Hurricane Idalia, Maui fires
The White House is requesting an additional $4 billion from Congress to bolster funding for FEMA following the Maui wildfires and Hurricane Idalia.
Meta’s WhatsApp is chasing big businesses in effort to finally capitalize on app’s popularity
As Meta tries to justify the $19 billion it paid for WhatsApp almost a decade ago, business messaging is the key.
Florida’s insurance industry is in flux as Idalia cleanup begins
Homeowners face uncertainty amid the upheaval that has emerged in Florida’s insurance industry in recent years.
How Wall Street’s REIT giants are reshaping U.S. real estate
Real estate investment trusts buy and manage commercial-scale properties. In recent years, the industry has repositioned for growth in residential housing.
Trump campaign aide told police officers to ‘go hang yourself’ at Jan. 6 riot
Dylan Quattrucci, the deputy director of Donald Trump’s 2024 campaign in New Hampshire, recorded the expletive-laden video at the foot of the Capitol.
UAW president says union has filed unfair labor practice charges against GM, Stellantis over contract talks
The Thursday filings followed the companies not responding to the union’s demands in a timely matter, United Auto Workers President Shawn Fain said.
SentinelOne CEO says the cybersecurity company is not for sale
SentinelOne wants to keep being a publicly traded company after going public in 2021, although it has underperformed some of its peers this year.
Biden says he’s ‘forever grateful’ to forces in Afghanistan on two-year anniversary of exit
Biden ordered the full withdrawal of approximately 3,000 U.S. troops from Afghanistan by Aug. 31 2021.
Proud Boy Joe Biggs receives 17 years in Jan. 6 seditious conspiracy case
The former Infowars correspondent, who was convicted of seditious conspiracy, “served as an instigator and leader” during the Capitol attack, federal prosecutors said.
Ozempic could be the next target of Medicare drug price negotiations – here’s why
Wall Street analysts expect Ozempic to be selected for price negotiations in 2025 due to the amount of money Medicare Part D already spends on the drug.
